, Volume 118, Issue 4, pp 410–418 | Cite as

Effects of neurotensin on EEG and event-related potentials in the rat

  • P. Robledo
  • W. M. Kaneko
  • C. L. Ehlers
Original Investigation


Neurotensin has neuromodulatory actions on multiple brain functions including motor, sensory and limbic processes. However, little is known about how neurotensin affects general arousal and/or attention states. The present study evaluated the effects of neurotensin on spontaneous brain activity as well as auditory evoked responses using electrophysiological measures. Electroencephalographic and event-related potential recordings were obtained in awake animals following intracerebroventricular administration of neurotensin (1.0, 10.0 and 30.0 µg). Twenty rats were implanted with recording electrodes in the frontal cortex, dorsal hippocampus, amygdala and nucleus accumbens. Neurotensin was found to produce a dose-related effect on behavior and electrophysiological measures. Lower doses (10 µg) produced no obvious behavioral changes, but significantly reduced EEG power in the lower frequency ranges (2–6 Hz) in the frontal cortex, the anterior amygdaloid complex and the nucleus accumbens. At higher doses (30 µg), rats appeared behaviorally inactivated, and EEG power was reduced in all structures in both the lower frequency ranges (2–6 Hz) and the higher frequency ranges (8–32 Hz). Auditory processing, as assessed by event-related potentials, was affected most significantly in amygdala and dorsal hippocampus. In the amygdala, the amplitude of the P3 component of the auditory event-related potential was increased significantly by doses of 10.0 and 30.0 µg. In the dorsal hippocampus, the amplitude and the area of the N1 component was increased dose dependently and significance was reached at the 30 µg dose. These electrophysiological findings indicate that neurotensin does not reduce the arousal level of the animals and in fact may enhance neurosensory processing in limbic areas through increased arousal and/or enhanced stimulus evaluation.

Key words

Amygdala Dorsal hippocampus ERPs Neuropeptides Nucleus accumbens Spectral power 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amaral DG, Price JL, Pitkanen A, Carmichael ST (1992) Anatomical organization of the primate amygdaloid complex. In: Aggleton JP (ed) The amygdala: neurobiological aspects of emotion, memory and mental dysfunction. Wiley-Liss, New York, pp 1–66Google Scholar
  2. Arthur DL, Starr A (1984) Task-relevant late positive component of the auditory event-related potential in monkeys resembles P300 in humans. Science 223:186–188Google Scholar
  3. Beauregard M, Ferron A, Descarries L (1992) Opposite effects of neurotensin on dopamine inhibition in different regions of the rat brain: and iontophoretic study. Neuroscience 47:613–619Google Scholar
  4. Benzing WC, Mufson EJ, Jennes L, Amstrong DM (1990) Reduction of neurotensin immunoreactivity in the amygdala in Alzheimer's disease. Brain Res 537:298–302Google Scholar
  5. Benzing WC, Mufson EJ, Armstrong DM (1993) Immunocytochemical distribution of peptidergic and cholinergic fibers in the human amygdala: their depletion in Alzheimer's desease and morphologic alteration in non-demented elderly with numerous senile plaques. Brain Res 625:125–138Google Scholar
  6. Bissette G, Nemeroff CB, Prange AJ Jr, Loosen PT, Lipton MA (1976) Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide, neurotensin. Nature 262:607Google Scholar
  7. Blaha CD, Phillips AG (1992) Pharmacological evidence of mechanisms underlying the effects of neurotensin and neuroleptics on in vivo dopamine efflux in the rat nucleus accumbens. Neuroscience 49:867–877Google Scholar
  8. Cador M, Robbins T, Everitt BJ (1989) Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum. Neuroscience 30:77–86Google Scholar
  9. Castel MN, Stutzmann JM, Lucas M, Lafforgue J, Blanchard JC (1989) Effects of ICV administration of neurotensin and analogs on EEG in rats. Peptides 10:95–101Google Scholar
  10. Castel MN, Morino P, Frey P, Terenius L, Hökfelt (1993) Immunohistochemical evidence for a nurotension striatonigral pathway in the rat brain. Neuroscience 55:833–847Google Scholar
  11. Coward DM (1992) General pharmacology of clozapine. Br J Psychiatry 160 [suppl 17]:5–11Google Scholar
  12. Dilts RP, Kalivas WP (1989) Autoradiographic localization of μ-opioid and neurotensin receptors within the mesolimbic dopamine system. Brain Res 488:311–327Google Scholar
  13. Ehlers CL (1984) Role of selected neuropeptides in the development of epileptiform discharges. In: Fariello RG, Morselli PL, Lloyd KG, Quesney LF, Engel J Jr (eds) Neurotransmitters, seizures and epilepsy II. Raven Press, N.Y., pp 295–304Google Scholar
  14. Ehlers CL (1988) ERP responses to ethanol and diazepam administration in squirrel monkeys. Alcohol 5:315–320Google Scholar
  15. Ehlers CL (1989) EEG and ERP responses to naloxone and ethanol in monkeys. Prog Neuro-psychopharmacol Biol Psychiatry 13:217–228Google Scholar
  16. Ehlers CL, Chaplin RI (1992) Long latency event-related potentials in rats: the effects of changes in stimulus parameters and neurochemical lesions. J Neural Transm 88:61–75Google Scholar
  17. Ehlers CL, Havstad JW (1982) Characterization of drug effects on the EEG power spectral band time series analysis. Psychopharmacol Bull 18:43–47Google Scholar
  18. Ehlers CL, Reed TK, Wang M, Lebrun CJ, Koob GF (1985) EEG effects of subcutaneous and intracerebroventricular injections of arginine vasopressin in the rat. Psychopharmacology 87:430–433Google Scholar
  19. Ehlers CL, Reed TK, Henriksen SJ (1986) Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 42:467–474Google Scholar
  20. Ehlers CL, Wall TL, Chaplin RI (1991) Long latency event related potentials in rats: effects of dopaminergic and serotonergic depletions. Pharmacol Biochem Behav 38:789–793Google Scholar
  21. Ehlers CL, Kaneko WM, Wall TL, Chaplin RI (1992) Effects of dizocilpine (MK-801) and ethanol on the EEG and event-related potentials (ERPS) in rats. Neuropsychopharmacology 31:369–378Google Scholar
  22. Ervin GN, Nemeroff CB (1988) Antagonization of the behavioral activation produced by direct stimulation of forebrain dopamine receptors caused by intra-accumbens injections of neurotensin. Neuropsychopharmacology 1:243–250Google Scholar
  23. Ervin GN, Birkermo LS, Nemeroff CB, Prange AJ Jr (1981) Neurotensin blocks certain amphetamine-induced behaviors. Nature 291:73–76Google Scholar
  24. Everitt BJ, Cador M, Robbins TW (1989) Interactions between the amygdala and ventral striatum in stimulus-reward associations: studies using a second-order schedule of sexual reinforcement. Neuroscience 30:63–75Google Scholar
  25. Ford APDW, Marsden CA (1990) In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin andd-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat. Brain Res 534:243–250Google Scholar
  26. Fuxe K, Von Euler G, Agnati LF, Merlo Pich E, O'Connor WT, Tanganelli S, Li XM, Tinner B, Cintra A, Carani C, Benfenati F (1992a) Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like effect action of neurotensin. Ann NY Acad Sci 668:186–203Google Scholar
  27. Fuxe K, O'Connor WT, Antonelli T, Osborne PG, Tanganelli S, Agnati LF, Ungerstedt U (1992b) Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatrum. Proc Natl Acad Sci USA 89:5591–5595Google Scholar
  28. Gallagher M, Graham PW, Holland PC (1990) The amygdala central nucleus and appetitive conditioning: lesions impair one class of conditioned behavior. J Neurosci 10:1906–1911Google Scholar
  29. Glimcher PW, Giovino AA, Hoebel BG (1987) Neurotensin self-injection in the ventral tegmental area. Brain Res 403:147–150Google Scholar
  30. Halgren E, Squires NK, Wilson CL, Rohrbaugh JW, Babb TL, Crandall PH (1980) Endogenous potentials generated in the human hippocampal formation and amygdala by infrequent events. Science 210:803–805Google Scholar
  31. Hillyard SA, Kutas M (1983) Electrophysiology of cognitive processing. Annu Rev Psychol 34:33–61Google Scholar
  32. Hökfelt T, Everitt BJ, Theodorson-Norheim E, Goldstein M (1984) Occurrence of neurotensin-like immunoreactivity in subpopulations of hypothalamic, mesencephalic and medullary catecholamine neurons. J Comp Neurol 22:543–559Google Scholar
  33. Jennes L, Stumpf WE, Kalivas PW (1982) Neurotensin: topographical distribution in rat brain by immunohistochemistry. J Comp Neurol 210:211–224Google Scholar
  34. Jolicoeur FB, Gagne MA, Rivest R, Drumheller A, St Pierre S (1993) A typical neuroleptic-like behavioral effects of neurotensin. Brain Res Bull 32:487–491Google Scholar
  35. Jones TA, Stockard JJ, Weidner WJ (1980) The effects of temperature and acute alcohol intoxication on brain stem auditory evoked potentials in the cat. Electroencephalogr Clin Neurophysiol 49:23–30Google Scholar
  36. Kalivas PW, Nemeroff CB, Prange AJ Jr (1984) Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing. Neuroscience 11:919–930Google Scholar
  37. Karper LP, Salloway MD, Seibyl JP, Krystal JH (1992) Prolonged postictal encephalopathy in two patients with clozapine-induced seizures. J Neuropsychiatr Clin Neurosci 4:454–457Google Scholar
  38. Kasckow J, Nemeroff CB (1991) The neurobiology of neurotensin: focus on neurotensin-dopamine interactions. Regul Pept 36:153–164Google Scholar
  39. Kelley AE, Cador M (1988) Behavioral evidence for differential neuropeptide modulation of the mesolimbic dopamine system. Ann NY Acad Sci 537:415–434Google Scholar
  40. Kelley AE, Delfs JM (1991) Dopamine and conditioned reinforcement II. Contrasting effects of amphetamine microinjection into the nucleus accumbens with peptide microinjection into the ventral tegmental area, Psychopharmacology 103:197–203Google Scholar
  41. Kelley AE, Cador M, Le Moal M (1989) Neurotensin, substance P, Neurokinin-alpha, and enkephalin: injection into the ventral tegmental area in the rat produces differential effects in operant responding. Psychopharmacology 97:243–252Google Scholar
  42. Köhler C, Chan-Palay V (1989) Neuropeptide receptors in the hippocampal region in the rat monkey and human brain. In: Chan-Palay V, Köhler C (eds) The hippocampus new vistas. Alan R Liss, New York, pp 179–181Google Scholar
  43. Luttinger D, Nemeroff CB, Mason GA, Frye GD, Breese GR, Prange AJ Jr (1981a) Enhancement of ethanol-induced sedation and hypothermia by centrally administered neurotensin, beta-endorphin and bombesin. Neuropharmacology 20:305–309Google Scholar
  44. Luttinger D, Nemeroff CB, King RA, Erwin GN, Prange AJ Jr (1981b) The effects of injection of neurotensin into the nucleus accumbens on behaviors mediated by the mesolimbic dopamine system in the rat. In: Chronister RB, de France JF (eds) The neurobiology of the nucleus accumbens. Hear Institute for Electrophysiological Research, Sebaseco, Maine, pp 322–332Google Scholar
  45. McClelland GR, Cooper SM, Pilgrim AJ (1990) A comparison of the central nervous system of haloperidol, chlopromazine and sulpiride in normal volunteers. Br J Clin Pharmacol 30:795–803Google Scholar
  46. Moyse E, Rostene M, Vial, Leonard K, Mazella J, Kitabgi P (1987) Distribution of neurotensin binding sites in rat brain: a light microscopic radioautographic study using monoiodo [125I]Tyr3neurotensin. Neuroscience 22:525–536Google Scholar
  47. Nemeroff CB (1986) The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia. Psychoneuroendocrinology 11:15–37Google Scholar
  48. Nemeroff CB, Bissette G, Prange AJ Jr, Loosen T, Barlow TS, Lipton MA (1977) Neurotensin: central nervous system effects of a hypothalamic peptide. Brain Res 128:485–496Google Scholar
  49. Nemeroff CB, Luttinger D, Hernandez DE, Mailman RB, Mason GA, Davis SD, Widerlov E, Frye GD, Kilts CD, Beaumont K, Breese GR, Prange AJ Jr (1983) Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies. J Pharmacol Exp Ther 225:337–345Google Scholar
  50. Nemeroff CB, Bissette G, Widerlov E, Beckman H, Gerner R, Manberg PJ, Lindstrom L, Prange AJ Jr, Gattaz WF (1989) Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosabulemia and premenstrual syndrome. J Neuropsychiatr Clin Neurosci 1:16–20Google Scholar
  51. O'Connor WT, Tanganelli S, Ungerstedt U, Fuxe K (1992) The effects of neurotensin on GABA and acetylcholine release in the dorsal striatum of the rat: an in vivo microdialysis study. Brain Res 573:209–216Google Scholar
  52. Osbahr AJ III, Nemeroff CB, Manberg PH, Prange AJ Jr (1979) Centrally administered neurotensin: activity in the Jolou-Couvoisier muscle relaxation test in mice, Eur J Pharmacol 54:299–302Google Scholar
  53. Palacios JM, Kuhar MJ (1981) Neurotensin receptors are located on dopamine-containing neurons in rat midbrain. Nature 294:587–589Google Scholar
  54. Pechnick RN, Wong CA, George R, Thurkauf A, Jacobson AE, Rice KC (1989) Comparison of the effects of the acute administration of dexoxadrol, levoxadrol, MK-801 and phencyclidine on body temperature in the rat. Neuropharmacology 28:829–835Google Scholar
  55. Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain. Plenum Press, New York, LondonGoogle Scholar
  56. Polich J (1987) Comparison of P300 from a passive tone sequence paradigm and an active discrimination task. Psychophysiology 24:41–46Google Scholar
  57. Polich J, Fisher A, Starr A (1983) A programmable multi-tone generator. Behav Res Methods Instr 15:39–41Google Scholar
  58. Quirion R, Chivels CC, Everist HD, Pert A (1985) Comparative localization of neurotensin receptors in nigrostriatal and mesolimbic dopaminergic terminals. Brain Res 327:385–389Google Scholar
  59. Roberts GW, Woodhams PL, Polak JM, Crow TJ (1984) Distribution of neuropeptides in the limbic system of the rat: the hippocampus. Neuroscience 11:35–77Google Scholar
  60. Robledo P, Koob GF (1993) Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration. Brain Res 622[1–2]:105–112Google Scholar
  61. Roth WT (1973) Auditory evoked responses to unpredictable stimuli. Psychophysiology 10:125–137Google Scholar
  62. Roth WT, Doyle CM, Pfefferbaum A, Kopell BS (1980) Effects of stimulus intensity on P300. In: Kornhuber HH, Deecke L (eds) Motivation, motor and sensory processes of the brain: electrical potentials, behavior, and clinical use. Elsevier, Amsterdam, Vol. 54, pp 296–300Google Scholar
  63. Schotte A, Leysen JE (1989) Autoradiographic evidence for the localization of high affinity neurotensin binding sites on dopaminergic nerve terminal in the nigrostriatal and mesolimbic pathways in the rat brain. J Chem Neuroanat 2:253–257Google Scholar
  64. Shi WX, Bunney BS (1992) Actions of neurotensin: a review of the electrophysiological studies. Ann NY Acad Sci 668:129–145Google Scholar
  65. Skoog KM, Cain S, Nemeroff CB (1986) Centrally administered neurotensin suppresses locomotor hyperactivity induced byd-amphetamine but not by scopolamine or caffeine. Neuropharmacology 25:777–782Google Scholar
  66. Squires NK, Squires KC, Hillyard SA (1975) Two varieties long-latency positive waves evoked by unpredictable auditory stimuli in man. Electroencephalogr Clin Neurophysiol 38:387–401Google Scholar
  67. Stowe ZN, Nemeroff CB (1991) The electrophysiological actions of neurotensin in the central nervous system. Life Sci 49:987–1002Google Scholar
  68. Tanganelli S, O'Connor WT, Ferraro L, Bianchi C, Beani L, Ungerstedt U (1994) Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens. Neuroscience 60:649–657Google Scholar
  69. Töröcsik A, Rakovska A, Görcs T, Vizi ES (1993) Effects of neurotensin and immunneutralization with anti-neurotensin serum on dopaminergic-cholinergic interaction in the striatum. Brain Res 612:306–312Google Scholar
  70. Uhl GR, Snyder SH (1977) Regional and subcellular distribution of brain neurotensin. Life Sci 19:1827–1832Google Scholar
  71. Widerlov E, Kilts CD, Mailman C, Nemeroff CB, McCown TJ, Prange AJ Jr, Bresse GR (1982) Increase in dopamine metabolites in rat brain by neurotensin. J Pharmacol Exp Ther 222:1–6Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • P. Robledo
    • 1
  • W. M. Kaneko
    • 1
  • C. L. Ehlers
    • 1
  1. 1.Department of Neuropharmacology, CVN-14The Scripps Research InstituteLa JollaUSA

Personalised recommendations